Literature DB >> 1947088

Intracranial aneurysms and vascular malformations: comparison of time-of-flight and phase-contrast MR angiography.

J Huston1, D A Rufenacht, R L Ehman, D O Wiebers.   

Abstract

Twenty-seven patients with 14 aneurysms and 17 vascular malformations were each examined with both time-of-flight (TF) and phase-contrast (PC) magnetic resonance angiography of the head. Three-dimensional (3D) PC imaging depicted the patent lumen of the aneurysms, while 3D TF imaging depicted the patent lumen and a subacute thrombus if present. The 3D PC techniques were superior to 3D TF methods in depicting aneurysms larger than 15 mm. PC angiography allowed velocity resolution of vascular lesions and yielded functional flow information by directly depicting collateral flow to vascular lesions. Artifacts present on TF images were due to substances with short T1, hemosiderin, and surgical clips. Artifacts present on PC images were due to flow-related aliasing. The results showed that PC techniques have specific advantages over TF techniques, including identification of large aneurysms, velocity resolution of vascular lesions, depiction of flow direction about the circle of Willis, and less degradation by artifacts.

Entities:  

Mesh:

Year:  1991        PMID: 1947088     DOI: 10.1148/radiology.181.3.1947088

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  30 in total

1.  MR digital subtraction angiography of cerebral arteriovenous malformations.

Authors:  K Tsuchiya; S Katase; A Yoshino; J Hachiya
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

Review 2.  Imaging of parasellar lesions.

Authors:  J Ruscalleda
Journal:  Eur Radiol       Date:  2005-01-28       Impact factor: 5.315

3.  HYPR TOF: time-resolved contrast-enhanced intracranial MR angiography using time-of-flight as the spatial constraint.

Authors:  Yijing Wu; Steven R Kecskemeti; Kevin Johnson; Kang Wang; Howard Rowley; Oliver Wieben; Charles Mistretta; Patrick Turski
Journal:  J Magn Reson Imaging       Date:  2011-02-01       Impact factor: 4.813

4.  Comparison of magnetic resonance angiography and conventional angiography in sickle cell disease: clinical significance and reliability.

Authors:  A Y Kandeel; R A Zimmerman; K Ohene-Frempong
Journal:  Neuroradiology       Date:  1996-07       Impact factor: 2.804

5.  Diagnosis of carotid-cavernous fistulas with magnetic resonance angiography--demonstrating the draining veins utilizing 3-D time-of-flight and 3-D phase-contrast techniques.

Authors:  F Ikawa; T Uozumi; K Kiya; K Kurisu; K Arita; M Sumida
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

6.  Usefulness of two-dimensional time-of-flight MR angiography combined with surface anatomy scanning for convexity lesions.

Authors:  B Pant; M Sumida; K Kurisu; K Arita; F Ikawa; K Migita; M Kutsuna; T Uozumi
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

7.  Usefulness of three-dimensional phase contrast MR angiography on arteriovenous malformations.

Authors:  B Pant; M Sumida; K Arita; A Tominaga; F Ikawa; K Kurisu
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

8.  Intraobserver and interobserver variability in CT angiography and MR angiography measurements of the size of cerebral aneurysms.

Authors:  Hye Jeong Kim; Dae Young Yoon; Eun Soo Kim; Hyung Jin Lee; Hong Jun Jeon; Jong Young Lee; Byung-Moon Cho
Journal:  Neuroradiology       Date:  2017-03-25       Impact factor: 2.804

9.  Aneurysms of the anterior communicating artery treated with Guglielmi detachable coils: follow-up with contrast-enhanced MR angiography.

Authors:  Xavier Leclerc; Jean-François Navez; Jean-Yves Gauvrit; Jean-Paul Lejeune; Jean-Pierre Pruvo
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

10.  Demonstration of the venous systems with gadolinium-enhanced three-dimensional phase-contrast MR venography.

Authors:  F Ikawa; M Sumida; T Uozumi; K Kiya; K Kurisu; K Arita; H Satoh
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.